Letter From the Chair

“Thank you for your interest in our department, and our outstanding faculty, students and staff who represent our broad range of programs and resources.

Faculty are actively engaged in the entry-level Pharm.D. program and our own graduate program, including one of the nation’s largest Ph.D. programs in pharmaceutical outcomes and policy, a research-focused residential M.S. program and an applied online M.S. program geared toward working professionals.

The department’s focus in research and graduate training is centered on the evaluation of drugs and related medical technology. This focus includes classic pharmacoepidemiologic and pharmacoeconomic work, as well as pharmaceutical health services research with a focus on quality and policy involving medication use. Our program has grown tremendously over the past five years with more to come. To find out more, please refer to our annual report and reach out or visit us in beautiful Florida to see one of the nation’s top 10 universities and top 5 pharmacy colleges.”

Annual Report


“This year, combined productivity has resulted in more studies, more publications and more impact on public health.”

Almut Winterstein, R.PH., PH.D., FISPE | Professor and Chai

Dr Winterstein, blue hexagon background

Department Highlights

30 Ph.D. Students And over 150 M.S. students

30 Manuscripts First-authored by graduate students

37 Countries Represented Diverse student population

18 Active Projects Extramurally Funded